Treatment of Constipation in Children

Initial Non-Pharmacological Approaches

The American Academy of Pediatrics recommends increasing fluid intake to maintain proper hydration and increasing dietary fiber intake through age-appropriate foods, such as fruits, vegetables, whole grains, and legumes, to help manage constipation in children 1
Regular physical activity appropriate to the child's age is also recommended to help manage constipation 2
Fruit juices containing sorbitol, such as prune, pear, and apple juices, can help increase stool frequency and water content in infants with constipation 3, 4

Dietary Recommendations

The Centers for Disease Control and Prevention recommends that infants continue breast-feeding on demand or use full-strength formula, and that older children maintain a regular diet with an emphasis on high-fiber foods, including starches, cereals, yogurt, fruits, and vegetables 5, 6
A diet that includes the "BRAT" foods (bananas, rice, applesauce, toast) can be helpful as part of the dietary management of constipation, while avoiding foods high in simple sugars and fats that can worsen constipation 5, 6

Pharmacological Management

The National Comprehensive Cancer Network recommends polyethylene glycol, lactulose, or sorbitol-containing juices as first-line laxative therapy for constipation in children, with dosing adjusted based on age and severity 2
Bisacodyl and glycerin suppositories can be used for more severe cases of constipation, with the goal of achieving one non-forced bowel movement every 1-2 days 2

Management Algorithm

The assessment phase of constipation management should include ruling out impaction, obstruction, and other causes of constipation, and identifying and treating underlying conditions, according to the National Comprehensive Cancer Network 2
The initial treatment phase should include dietary modifications, laxative therapy, and manual disimpaction if necessary, with the goal of achieving regular bowel movements 2, 1
The maintenance phase should include continued dietary modifications, adjusted laxative dosing, and gradual tapering of medications as bowel habits normalize, according to the Centers for Disease Control and Prevention 2, 5

Common Pitfalls to Avoid

Relying solely on dietary changes without addressing impaction if present can worsen constipation, according to the National Comprehensive Cancer Network 2
Using stimulant laxatives as first-line therapy instead of osmotic agents can also worsen constipation, and is not recommended by the National Comprehensive Cancer Network 2

Treatment Options for Pediatric Constipation

Initial Assessment and Non-Pharmacological Approaches

Constipation in children is usually functional without an organic cause, but assessment should rule out impaction, obstruction, and other treatable causes such as hypercalcemia, hypokalemia, hypothyroidism, and diabetes mellitus 7
Correct toilet posture is essential - children need secure seating with buttock support, foot support, and comfortable hip abduction to enable relaxed voiding 8

Pharmacological Management Algorithm

Step 1: Disimpaction (if needed)

For fecal impaction, glycerin suppositories may be administered or manual disimpaction performed 7
For opioid-induced constipation: stimulant laxatives with or without stool softeners 7

Step 3: Weaning

Maintenance phase may need to continue for many months before the child regains normal bowel motility and rectal perception 8

Special Considerations

Constipation management should be aggressive, as it can impact other conditions - it has been shown to decrease urinary tract infections and reduce the need for intervention in patients with vesicoureteral reflux 8, 9

Common Pitfalls to Avoid

Premature discontinuation of treatment - parents often cease treatment too soon before the child regains bowel motility and rectal perception 8

Constipation Management in Pediatrics

Dietary Recommendations

The American Academy of Pediatrics recommends that fruits and vegetables should not be restricted for fluid content in children with constipation 10

Special Considerations

Aggressive constipation management in children with vesicoureteral reflux can decrease urinary tract infections and reduce the need for intervention, although the specific guideline society is not mentioned in the provided reference [@2@ is not available, however 10 is the only available reference]

Management of Constipation in Children

Recommended Treatment Options

Glycerin suppositories are the recommended first-line suppository option for a 2-year-old child with constipation, as they act as a rectal stimulant through mild irritant action and are safe for this age group 11
The American Academy of Pediatrics recommends performing a digital rectal examination to identify if the rectum is full or if fecal impaction is present, and if impaction is present, suppositories are preferred first-line therapy 12

Contraindications and Precautions

Suppositories or enemas should not be used in children with neutropenia, thrombocytopenia, recent colorectal surgery, anal trauma, or severe colitis 12

Treatment Outcomes

Using suppositories alone without follow-up maintenance therapy leads to high relapse rates, with 40-50% of children experiencing relapse within 5 years, highlighting the importance of maintenance therapy 11

Constipation Management in Infants

Inappropriate Medications for Infant Constipation

The American Academy of Pediatrics and other guideline societies do not provide recommendations for the use of bisacodyl in infants under 6 months of age, as there is no safety or efficacy data for its use in this age group, and safer alternatives exist specifically for young infants 13, 14

Medication Safety and Efficacy

Bisacodyl is classified as a stimulant laxative, and its use is not recommended as first-line therapy in pediatric constipation, with guidelines from societies such as the National Comprehensive Cancer Network discussing its use only in older children and adults 13, 14

Treatment of Pediatric Constipation

Non-Pharmacological Management

The American Academy of Pediatrics recommends implementing a regular toileting schedule, such as voiding in the morning, twice during school, after school, at dinner, and before bed, to help manage constipation in children 15

Pharmacological Maintenance Therapy

The North American Society for Pediatric Gastroenterology, Hepatology and Nutrition recommends polyethylene glycol (PEG) 3350 as the laxative of first choice for children 6 months and older, with an initial dosing of 0.8-1 g/kg/day, and a goal of producing 2-3 soft, painless stools daily, although the exact strength of evidence is not provided 15

Management of Chronic Constipation in Children

Initial Assessment and Treatment

The American Academy of Pediatrics and other guideline societies recommend ruling out organic causes, including hypothyroidism, hypercalcemia, hypokalemia, and diabetes mellitus, before initiating treatment for constipation in children 16
Manual disimpaction may be performed as an alternative to glycerin suppositories for children with constipation, according to the National Comprehensive Cancer Network 16

Non-Pharmacological Foundation and Behavioral Modifications

Establishing a regular toileting schedule is recommended, though full continence may not be achieved until the second decade, as suggested by the Nature Reviews Nephrology 17

Pharmacological Maintenance Therapy and Monitoring

Stool softeners alone, like docusate, are ineffective and not recommended for the treatment of constipation in children, according to the Journal of the National Comprehensive Cancer Network 18
Treatment efficacy should be evaluated by stool frequency and consistency, absence of pain with defecation, and weight gain and growth parameters, with guidance from the Nature Reviews Nephrology 17

Critical Warnings and Long-Term Considerations

Rectal bleeding, nausea, bloating, cramping, or abdominal pain, and diarrhea are critical warnings that require immediate evaluation and potential cessation of polyethylene glycol (PEG) treatment, as indicated by the Journal of the National Comprehensive Cancer Network 16, 18

Chronic Constipation Management in Children

Initial Assessment and Diagnosis

The American Academy of Pediatrics recommends a thorough history and physical examination, including a digital rectal exam, to assess for fecal impaction and rule out anatomical abnormalities 19
A frequency-volume chart or bowel diary for at least 1 week provides objective data and helps monitor treatment response 19
The diagnosis of functional constipation is clinical, based on symptoms such as infrequent defecation, painful or hard bowel movements, and large diameter stools 19

Treatment and Management

The American Academy of Pediatrics suggests explaining normal bowel function and the pathogenesis of constipation to the family, and establishing a regular toileting schedule 19
Aggressive treatment is essential, as chronic constipation is a lifelong problem that can lead to complications including rectal prolapse, hemorrhoids, and intestinal perforation 20
Maintenance therapy must continue for many months before the child regains normal bowel motility and rectal perception, with a goal of 2-3 soft, painless stools daily 19

Key Clinical Findings and Associations in Pediatric Constipation

Functional Causes

Functional constipation is the predominant form in children and is attributed to learned bowel habits, persistence of infantile voiding patterns, or maturational delay. 21
Infrequent defecation is defined as fewer than three bowel movements per week in children. 22
Children often report a sensation of incomplete evacuation or anorectal blockage. 22

Organic Causes – Anatomic and Neurologic

Delayed passage of the first stool beyond 48 hours after birth is a red‑flag sign for Hirschsprung disease, which requires surgical correction. 23
Spinal cord anomalies, including tethered cord syndrome, can cause constipation by disrupting bowel innervation. 23
Cutaneous markers on the lower back (e.g., dimples, hair tufts, hemangiomas) may indicate underlying spinal dysraphism. 23
Progressive lower‑limb sensorimotor disturbances, bladder dysfunction (urinary incontinence or recurrent UTIs), orthopedic deformities (scoliosis, gait abnormalities), or a history of delayed toilet training are additional clues to neurologic involvement. 23

Organic Causes – Metabolic and Endocrine

Treatable metabolic disorders such as hypercalcemia, hypothyroidism, hypokalemia, and diabetes mellitus can present with constipation and should be screened for. 22

Organic Causes – Genetic Syndromes

Williams syndrome is linked to chronic lifelong constipation that often necessitates aggressive therapy; complications include rectal prolapse, hemorrhoids, intestinal perforation, and early‑onset diverticulitis in adolescence. 24
In children with Williams syndrome, 50 % have bladder diverticula, 60 % exhibit detrusor overactivity causing urinary frequency, and 25 % have a history of urinary tract infections. 24

Dysfunctional Voiding and Pelvic‑Floor Disorders

Dysfunctional voiding arises from paradoxical contraction or incomplete relaxation of the pelvic floor and external anal sphincter during defecation. 21
Uroflowmetry in affected children typically shows staccato or plateau‑shaped flow patterns. 21
This condition is associated with incomplete bladder emptying and a higher incidence of urinary tract infections. 21
Treating constipation alone resolves bladder emptying abnormalities in approximately 66 % of children with dysfunctional voiding. 21
In children who have both constipation and urinary symptoms, constipation‑focused therapy leads to resolution of daytime wetting in 89 % and nighttime wetting in 63 % of cases. 21

Urologic Associations

Bladder dysfunction and urinary tract abnormalities frequently coexist with constipation in pediatric patients. 24

Evidence level: The cited studies provide observational and cohort data; specific grades of recommendation are not stated in the source material.

Mechanism of Polyethylene Glycol in Pediatric Functional Constipation

Pharmacologic Action

In children aged ≥ 6 months with functional constipation, polyethylene glycol (PEG) works as an osmotic laxative by sequestering fluid within the intestinal lumen, thereby increasing stool water content and facilitating soft, painless bowel movements. This mechanism is supported by evidence from two Gut journal studies (2020) 25, 26.

Lactulose Dosing and Safety in Infants

Dosage Conversion

Safety Considerations

Management of Constipation in Children with Enuresis

Impact on Enuresis Treatment

Treating constipation is essential for successful management of urinary enuresis; failure to address concurrent constipation significantly reduces the likelihood of achieving dryness in children with enuresis. 28

Adverse Effects of Lactulose and Use of Stimulant Laxatives in Pediatric Constipation

Adverse Effects of Lactulose

In children with functional constipation, lactulose commonly causes flatulence, abdominal pain, bloating, nausea, and diarrhea; these effects are dose‑dependent and can be managed by reducing the dose. 29

Recommendations on Stimulant Laxatives

Stimulant laxatives such as bisacodyl and senna should not be used as first‑line therapy for pediatric constipation; they are reserved only for rescue treatment when other agents fail. 29